China’s Fosun Pharma Invests $158 Mln For 60% Stake In Singapore Cancer Treatment Centers |
| June 07, 2022 | June 2022 Bond Updates |
|
Purchase to help expansion in Southeast Asia |
| View more at: https://www.forbes.com/sites/russellflannery/2022/06/06/chinas-fosun-pharma-invests-158-mln-for-60-stake-in-singapore-cancer-treatment-centers/ |
| Related News |